Spark BioPharma
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $45M
Investors
- 13
About Spark BioPharma
Founded in 2016 and based in Seoul, South Korea, Spark BioPharma, Inc. develops a technology platform for drug screening and target identification for anti-cancer drug candidates. In April 2022, Spark BioPharma, Inc. The April investment will help Spark BioPharma, Inc. with its domestic and overseas clinical trials and develop technology exported to global pharmaceutical companies.
Who invested in Spark BioPharma
13 investors across 4 rounds
See all investors in Spark BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spark BioPharma
Who invested in Spark BioPharma?
Spark BioPharma has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spark BioPharma raised?
Spark BioPharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Spark BioPharma last raise money?
Spark BioPharma's most recent round on record is a Series C, in Apr 2022.
What does Spark BioPharma do?
Founded in 2016 and based in Seoul, South Korea, Spark BioPharma, Inc.
Where is Spark BioPharma headquartered?
Spark BioPharma is headquartered in Seoul, South Korea.
Which VCs invest in companies like Spark BioPharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Spark BioPharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Spark BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.